- Home
- AMPY vs TLSA Comparison
AMPY vs TLSA Comparison
Compare AMPY & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMPY | TLSA |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.1M | 200.8M |
| IPO Year | 2011 | 2000 |
Fundamental Metrics
Financial Performance| Metric | AMPY | TLSA |
|---|---|---|
| Price | $4.59 | $1.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 643.6K | 433.6K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $275,827,100.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.27 | $0.63 |
| 52 Week High | $6.62 | $2.60 |
Technical Indicators
Market Signals| Indicator | AMPY | TLSA |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 33.27 |
| Support Level | $4.53 | $1.39 |
| Resistance Level | $4.71 | $1.60 |
| Average True Range (ATR) | 0.22 | 0.17 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 4.69 | 23.33 |
Price Performance
Historical ComparisonAbout AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.